Tag Archives: HPP

Best Safest Stocks To Invest In Right Now

The stock market’s relentless march upward has pushed the prices of many companies higher. As investors bid up good and bad businesses alike, that can make it hard to discern which companies are the best dividend growth stocks for long-term investors.

That’s especially true in the world of dividend stocks, where income-starved investors face great temptation to reach for high-dividend stocks that offer juicy yields.

Fortunately, Simply Safe Dividends identified the 10 best dividend growth stocks that investors can rely on for secure, fast-growing income.

These companies all have very healthy Dividend Safety Scores, which measure a firm’s most important financial metrics to gauge how likely it is to cut its dividend in the future.

Let’s take a look at 10 of the safest dividend growth stocks in the market. These companies generate excellent free cash flow, maintain safe payout ratios, are committed to rewarding shareholders with healthy dividend increases and have bright long-term outlooks.

Best Safest Stocks To Invest In Right Now: Portland General Electric Company(POR)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Portland General Electric (POR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Opus Investment Management Inc. lowered its holdings in Portland General Electric (NYSE:POR) by 8.1% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 95,200 shares of the utilities provider’s stock after selling 8,400 shares during the quarter. Opus Investment Management Inc. owned about 0.11% of Portland General Electric worth $3,857,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    ValuEngine upgraded shares of Portland General Electric (NYSE:POR) from a sell rating to a hold rating in a report issued on Friday.

    Several other equities research analysts also recently commented on POR. Guggenheim reiterated a hold rating and set a $40.00 target price on shares of Portland General Electric in a research report on Friday, February 23rd. Bank of America downgraded shares of Portland General Electric from a neutral rating to an underperform rating and cut their target price for the stock from $41.00 to $39.00 in a research report on Tuesday, March 6th. JPMorgan Chase & Co. cut their target price on shares of Portland General Electric from $42.00 to $41.00 and set a neutral rating on the stock in a research report on Tuesday, March 27th. Finally, Zacks Investment Research upgraded shares of Portland General Electric from a sell rating to a hold rating in a research report on Wednesday, May 2nd. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company. The stock has an average rating of Hold and a consensus target price of $42.44.

Best Safest Stocks To Invest In Right Now: Schweitzer-Mauduit International Inc.(SWM)

Advisors’ Opinion:

Best Safest Stocks To Invest In Right Now: Intrepid Potash, Inc(IPI)

Advisors’ Opinion:

  • [By Lisa Levin]

    On Wednesday, the materials shares gained 0.17 percent. Meanwhile, top gainers in the sector included Intrepid Potash, Inc. (NYSE: IPI), up 20 percent, and Silgan Holdings Inc. (NASDAQ: SLGN), up 7 percent.

  • [By Lisa Levin] Gainers
    Daré Bioscience, Inc. (NASDAQ: DARE) shares climbed 54.2 percent to $1.25 on news that the company entered into worldwide license agreement for Juniper Pharmaceuticals' intravaginal ring technology platform.
    Travelzoo (NASDAQ: TZOO) climbed 21.3 percent to $9.40 following strong Q1 results.
    Intrepid Potash, Inc. (NYSE: IPI) gained 16.5 percent to $4.60.
    K12 Inc. (NYSE: LRN) shares rose 11.2 percent to $15.4206 following Q3 results.
    Chicago Bridge & Iron Company N.V. (NYSE: CBI) shares rose 11 percent to $15.3289. McDermott issued a release reiterating rejection of Subsea 7's offer.
    Six Flags Entertainment Corporation (NYSE: SIX) shares gained 9.2 percent to $64.61 as the company posted a narrower-than-expected loss for its first quarter.
    Tupperware Brands Corporation (NYSE: TUP) surged 8.5 percent to $46.00 as the company posted in-line quarterly earnings.
    Carlisle Companies Incorporated (NYSE: CSL) climbed 7.5 percent to $107.22 after reporting Q1 results.
    Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 6.1 percent to $14.78. B. Riley initiated coverage on Allena Pharmaceuticals with a Buy rating.
    Texas Instruments Incorporated (NASDAQ: TXN) rose 4.6 percent to $102.90 after the company reported stronger-than-expected earnings for its first quarter on Tuesday.
    Credit Suisse Group AG (NYSE: CS) rose 4.5 percent to $17.03 following strong Q1 results.
    STMicroelectronics N.V. (NYSE: STM) rose 4.2 percent to $22.20 after reporting Q1 results.

    Check out these big penny stock gainers and losers

  • [By Dan Caplinger]

    Stocks rebounded on Wednesday, with the Dow Jones Industrial Average climbing back from triple-digit losses early in the session to finish with a modest gain. Market participants were initially nervous because of the continued upward pressure on interest rates and their potential negative impact on the U.S. economy. But later in the day, confidence returned, and the steadfast market reversed course. Several individual stocks had much larger advances. Norfolk Southern (NYSE:NSC), Six Flags Entertainment (NYSE:SIX), and Intrepid Potash (NYSE:IPI) were among the best performers on the day. Here’s why they did so well.

Best Safest Stocks To Invest In Right Now: Evolving Systems, Inc.(EVOL)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Evolving Systems (NASDAQ: EVOL) and Zscaler (NASDAQ:ZS) are both computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation.

Best Safest Stocks To Invest In Right Now: Taseko Mines Limited(TGB)

Advisors’ Opinion:

  • [By Logan Wallace]

    Taseko Mines (NYSEAMERICAN:TGB) (TSE:TKO) has earned a consensus rating of “Buy” from the seven research firms that are currently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company.

Best Safest Stocks To Invest In Right Now: Hudson Pacific Properties, Inc.(HPP)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Forestar Group (NYSE: FOR) and Hudson Pacific Properties (NYSE:HPP) are both finance companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and profitability.

  • [By Stephan Byrd]

    Hudson Pacific Properties (NYSE:HPP) EVP Sanford Dale Shimoda sold 5,000 shares of the firm’s stock in a transaction dated Wednesday, June 6th. The stock was sold at an average price of $35.96, for a total transaction of $179,800.00. Following the completion of the transaction, the executive vice president now owns 89,478 shares of the company’s stock, valued at $3,217,628.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

  • [By Max Byerly]

    Hudson Pacific Properties (NYSE:HPP) EVP Sanford Dale Shimoda sold 2,000 shares of the company’s stock in a transaction dated Friday, June 1st. The stock was sold at an average price of $35.72, for a total transaction of $71,440.00. Following the completion of the transaction, the executive vice president now owns 94,478 shares of the company’s stock, valued at approximately $3,374,754.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

  • [By Chris Lange]

    Hudson Pacific Properties Inc. (NYSE: HPP) was started as a Buy at Merrill Lynch.

    L Brands Inc. (NYSE: LB) was maintained as Overweight at Morgan Stanley and assigned a price target of $56 (versus a $35.22 close).

best shares to invest in today

This past year was a very good one for the Dow Jones Industrial Average. The blue-chip index saw 25 of its 30 stocks post share price gains for 2017, and the index closed the year up more than 24%.

There were two big winners in 2017 and three more stocks that posted very solid gains above 40%:

Boeing Co. (NYSE: BA), up 89% Caterpillar Inc. (NYSE: CAT), up 68.9% Visa Inc. (NYSE: V), up 46.1% Apple Inc. (NASDAQ: AAPL), up 46.1% Wal-Mart Stores Inc. (NYSE: WMT), up 42.9%.

A stronger global economy contributed to the fortunes of at least two of these firms. while lower U.S. unemployment and improving wages helped the more consumer oriented companies post their gains.

Boeing

This aerospace and defense giant simply defied gravity in 2017. The stock’s upward trajectory started early and didn’t let up for the entire year. The company will end the year with net new orders of more than 850 and operating cash flow north of $12 billion. The big question, of course, is can the company keep it up through 2018? Could Boeing’s stock price actually nearly double again? That does not seem possible, but the company appears poised for another very good year.

best shares to invest in today: ITT Corporation(ITT)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Shares of General Electric have dropped 3.8% so far this year, with everything from its accounting to weaker margins being blamed for its weakness. Barclays’ Scott Davis and team, however, spoke with a source they call the “smartest man in the room,” who just so happens to be “nibbling” on General Electric now. They explain why and offer his views on Honeywell International (HON), Emerson Electric (EMR), and ITT (ITT) as well:

best shares to invest in today: Dynavax Technologies Corporation(DVAX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Dynavax Technologies Corporation (NASDAQ: DVAX) shares shot up 73 percent to $15.99 as the company announced that the Vaccines and Related Biological Products Advisory Committee of the U.S. Food and Drug Administration voted 12-1 in support of the company’s Hepatitis B vaccine, HEPLISAV-B. RBC Capital upgraded Dynavax from Sector Perform to Outperform.

  • [By Cooper Creagan]

    The same is true for Dynavax Technologies Corp. (Nasdaq: DVAX). A quick Night Trade of DVAX would’ve netted a whopping 230% in just a few months – and this can all be done from the comfort of your own home.

  • [By Lisa Levin]

    Dynavax Technologies Corporation (NASDAQ: DVAX) shares were also up, gaining 17 percent to $6.88 after the company on Friday presented updated data for SD-101 in combination with KEYTRUDA.

best shares to invest in today: Hudson Pacific Properties, Inc.(HPP)

Advisors’ Opinion:

  • [By Lisa Levin]

    Here is the list of stocks going ex-dividend on Friday.

    Douglas Dynamics Inc (NYSE: PLOW) – $0.2350 dividend, 2.9183 percent yield
    Tiffany & Co. (NYSE: TIF) – $0.4500 dividend, 2.6758 percent yield
    PulteGroup, Inc. (NYSE: PHM) – $0.0900 dividend, 1.7078 percent yield
    Leidos Holdings, Inc. (NYSE: LDOS) – $0.3200 dividend, 3.0851 percent yield
    Tupperware Brands Corporation (NYSE: TUP) – $0.6800 dividend, 4.1756 percent yield
    Hudson Pacific Properties Inc (NYSE: HPP) – $0.2000 dividend, 2.36

best shares to invest in today: Golfsmith International Holdings Inc.(GOLF)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Tuesday, our Under the Radar Moversnewsletter suggestedshorting small cap golf equipment stockAcushnet Holdings Corp (NYSE: GOLF):

    Acushnet Holdings has been on our watchlist for a while too, but it’s only been in the past few days we’ve seen the cracks start to appear.

best shares to invest in today: Headwaters Incorporated(HW)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Building products provider Headwaters (HW) said Sunday that it has agreed to be acquired by Australian construction materials supplier Boral for $24.25 per share, or $2.6 billion, in cash.

  • [By WWW.THESTREET.COM]

    Cramer was bearish on Headwaters (HW) , EnergySolutions (ES) , Western Refining (WNR) and Horizon Pharmaceuticals (HZNP) .

    No-Huddle Offense

best shares to invest in today: Citigroup Inc.(C)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Some money managers are indeed preparing for Armageddon, expecting a thin summer trading season to usher in the bear. But Cramer said that, ultimately, what happens in Washington has little impact on the earnings of stocks like Walmart (WMT) , Coca-Cola (KO) or Citigroup (C) . It also has no correlation to the 17.8% move in Nvidia (NVDA) , nor the 12.8% jump in Electronic Arts (EA) .

  • [By Ben Levisohn]

    So we find ourselves in the position we have for most of this year: positive on the market averages but less confident in what stocks to buy. While banks have clearly been the flavor of the day we have generally avoided those names. Both Citigroup (C) and Bank of America (BAC) are only now hitting six year highs and we have never advocated chasing winners. Meanwhile the staid, safe defensive stocks (value) like P&G (PG), Coke (KO), and Philip Morris (PM) are lagging. The dichotomy might be illustrated by retailers where Best Buy has been roaring while Gap Stores has been tanking…

  • [By WWW.THESTREET.COM]

    Bharara’s office also secured major settlements with some of the country’s biggest banks, including Citibank (C) and JPMorgan Chase (JPM) . In 2014, it reached a $1.2 billion agreement with Toyota (TM) over unintended acceleration by its cars.

  • [By Ben Levisohn]

    Citigroup (C) has declined0.5% to$58.09 after its earnings topped the Street consensus but its sales fell shortof analyst expectations.

    United Continental Holdings (UAL) has dropped 1.7% to$72.50 despite beating earnings and revenue forecasts.

  • [By Stephen Mack]

    But here’s the thing: One of those banks, Citigroup Inc. (NYSE: C), just rose 14.3% in a four-week period, leaving Money Morning Options Trading Specialist Tom Gentile to wonder, “how much better can they do?”

Top 10 Medical Stocks To Invest In Right Now

Thesis: The threat to enforce federal marijuana laws might backfire by pushing Congress to legalize marijuana on the federal level. While in the short term, marijuana related stocks might suffer, if legislation is passed and signed into law, it would not only ease fears, but also make it more likely that more states will follow along with the pot legalization trend. This will have a long term positive effect on marijuana stocks.

The Threat

Right now, even though it flies in the face of reality and evidence, marijuana is listed as a schedule one drug: a drug with high potential for abuse, no currently accepted medical treatment use in the U.S., and lack of accepted safety for use of the drug or substance under medical supervision.

President Trump has threatened to increase enforcement of federal cannabis laws. One might think that this will have a negative impact on marijuana and marijuana related stocks like Aurora Cannabis (OTCQB:ACBFF), General Cannabis (OTCQB:CANN), Americann (OTCQX:ACAN), and MassRoots (OTCQB:MSRT), and if implemented it probably would be devastating, both to publicly traded marijuana companies, and to local companies in regions that have legalized pot.

Top 10 Medical Stocks To Invest In Right Now: iShares Mortgage Real Estate Capped (REM)

Advisors’ Opinion:

  • [By Donald van Deventer]

    The latest implied forward rate forecast from Kamakura Corporation shows projected 10-year U.S. Treasury yields differing -0.07% to 0.03% from last week while fixed rate mortgage yields varied by -0.01% to 0.08%. Mortgage yields, determined by the Monday through Wednesday weekly survey of the Federal Home Loan Mortgage Corporation, lag Treasury movements simply because of the 3-day yield calculation used in the Primary Mortgage Market Survey. The 10-year U.S. Treasury yield is projected to rise from 2.92% at Thursday’s close (down 0.06% from last week) to 3.374% (down 0.06% from last week) in one year. The 10-year U.S. Treasury yield in ten years is forecast to reach 4.639%, 1 basis point lower than last week. The 15-year fixed rate mortgage rate is forecast to rise from the effective yield of 3.69% on Thursday (down 0.001% from last week) to 4.222% (down 0.006% from last week) in one year and 6.29% in 10 years, up 0.038% from last week. We explain the background for these calculations in the rest of this note, along with some mortgage servicing rights metrics. The forecast allows investors in exchange traded U.S. Treasury funds (TLT) (TBT), total return bond funds (BOND), municipal bonds (NUV) and exchange traded mortgage funds (REM) to assess likely total returns over the next 120 months. Treasury-related exchange traded funds affected by the forward rates include:

Top 10 Medical Stocks To Invest In Right Now: Callon Petroleum Company(CPE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Thursday’s regular session.

Top 10 Medical Stocks To Invest In Right Now: Bayer Aktiengesellschaft (BAYRY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    This type of spin-off is not uncommon among German companies, as they streamline their portfolios to focus on the where they have more competitive advantages in the long term. For instance, in the recent past, Siemens (OTCPK:SIEGY) has split out Osram (OTC:OSAGY) and Bayer (OTCPK:BAYRY) has performed the spin-off of Covestro (OTCPK:CVXTY), something that Rheinmetall is likely to do in the near future because its auto unit has reached peak margins, and therefore this is the best time to spin-off the business.

  • [By SEEKINGALPHA.COM]

    The Regeneron press release in November for its Q3 2017 financial and operating results reaffirmed Eylea’s full year 2017 U.S. net product sales growth of approximately 10% over 2016, which could be about $1 billion. From our model, we see the Q4 total revenues for Eylea, excluding sales outside the United States from Regeneron’s collaborative partner Bayer AG (OTCPK:BAYRY), of $1.2 billion, or a 17% increase year-on-year. REGN stock has a forward P/E ratio of 21.83 as of December 8, 2017, while the current trailing P/E is 34.57.

  • [By SEEKINGALPHA.COM]

    Fertilizers are only one input when it comes to farming, the equipment business has suffered, and seed suppliers are certainly concerned. Perhaps that is why another merger occurred last week between Monsanto (NYSE:MON) and Bayer (OTCPK:BAYRY). Bayer AG agreed to buy the U.S. seed manufacturer for $128 per share or approximately $47 billion creating a mammoth company with a combined value of almost $134.5 billion. The $128 per share price works out to a valuation of around 16 times earnings, which is cheap in a market where the average of S&P 500 stocks is trading at over 26.5 times earnings. However, the weakness in the agricultural sector caused disappointing earnings for Monsanto in the third quarter and a downbeat outlook for the future caused MON to accept Bayer’s bid. Bayer bought Monsanto at a low price, lowering the risk of the transaction for the German health care and agricultural giant.

  • [By Todd Campbell]

    Nektar Therapeutics is working with Bayer AG (NASDAQOTH:BAYRY) on an inhaledversion of Amikacin, an anti-bacterial that if successful in trials could be used alongside standard of care to treat gram-negative pneumonia in intubated and mechanically ventilated patients. If it’s eventually approved in the U.S., Nektar Therapeutics will receive a flat 30% royalty on sales. It’s also working with Bayer on an inhaled powder formulation of Cipro that could be used to treat chronic lung infections in cystic fibrosis patients. Top-line phase 3 results on both drugs should be available this year.

  • [By SEEKINGALPHA.COM]

    As the graphic below shows, ImmunoGen’s product pipeline is potentially significant. Furthermore, it is impressive to see the involvement and partnerships in these early stage compounds by some of the world’s leading pharmaceutical and biotech companies. This includes firms like Amgen (NASDAQ:AMGN), Roche (OTCQX:RHHBY), Bayer (OTCPK:BAYRY), Sanofi (NYSE:SNY), Eli Lilly (NYSE:LLY), and Novartis (NYSE:NVS).

Top 10 Medical Stocks To Invest In Right Now: WPP plc(WPPGY)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    WPP plc (WPPGY) — Most of WPP’s public websites were rendered inaccessible after the world’s biggest advertising group said its IT systems were the focus of a suspected cyberattack. Shares traded down almost 1% in early afternoon.

Top 10 Medical Stocks To Invest In Right Now: Entercom Communications Corporation(ETM)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap radio broadcasting stock Entercom Communications Corp (NYSE: ETM), a potential peer of Emmis Communications Corporation (NASDAQ: EMMS), Saga Communications (NYSEAMERICAN: SGA) and troubled Cumulus Media (NASDAQ: CMLS), is the tenth most shorted stock on the NYSE with short interest of 45.06% according to Highshortnterest.com.

Top 10 Medical Stocks To Invest In Right Now: GlaxoSmithKline PLC(GSK)

Advisors’ Opinion:

  • [By Todd Campbell]

    Also, like in hepatitis C, competitors are attempting to win away market share. For example,ViiV Healthcare, a joint venture spearheaded by GlaxoSmithKline(NYSE:GSK), is actively pursuing new HIV therapies that could make it more difficult for Gilead Sciences to maintain its market share dominance. In December, ViiV announced that a single tablet, two-drug combination that includes Johnson & Johnson’s Edurant met its primary endpoint in phase 3 studies. A filing for FDA approval is slated for this year.

  • [By WWW.MONEYSHOW.COM]

    Donald Trump understands how regulation harms both businesses and consumers, discouraging innovation and raising costs. In a recent news conference, he pledged to “cut regulations by 75%, maybe more.”  This is good news indeed for drug companies like GlaxoSmithKline (GSK).

  • [By Paul Ausick]

    GlaxoSmithKline plc (NYSE: GSK) dropped about 1% Wednesday to post a new 52-week low of $34.52 after closing at $34.86 on Tuesday. The stock’s 52-week high is $44.54. Volume of around 4.8 million was about equal to the daily average. The company’s HIV drug is being challenged by a potentially better drug from competitor Gilead Sciences.

  • [By Keith Speights]

    Gilead’s primary rival in the HIV market is Viiv Healthcare, which is majority-owned byGlaxoSmithKline (NYSE:GSK).The company recently announced positive results from a late-stage clinical study of its HIV drug Tivicay combined with Johnson & Johnson’s Edurant.

  • [By Sean Williams]

    Third, in late March, Mylan announced that the Food and Drug Administration had rejected its application to market a generic version of GlaxoSmithKline’s (NYSE:GSK) blockbuster asthma and COPD inhalable drug, Advair. GlaxoSmithKline’s Advair lost patent protection more than six years ago, but only within the past couple of years did the FDA lay out a course for generic drug producers to follow in order to get a generic version of the drug approved. Meanwhile, Glaxo still enjoys blockbuster sales of Advair as generic versions of the drug have yet to hit the market.

Top 10 Medical Stocks To Invest In Right Now: Royal Gold Inc.(RGLD)

Advisors’ Opinion:

  • [By Scott Levine]

    Climbing nearly 6% through January, the price of gold outpaced the meager gain — approximately 1% — of the S&P 500. Unsurprisingly, many of the market’s largest gold stocks enjoyed double-digit gains, including AngloGold Ashanti (NYSE:AU), Barrick Gold (NYSE:ABX), IAMGOLD (NYSE:IAG), and Royal Gold (NASDAQ:RGLD).

  • [By Alex McGuire]

    This list ranks gold dividend stocks in the mining sector by dividend yield. And it also includes one of our top gold stock recommendations of 2017…

    Gold Dividend Stock Share Price Year-to-Date Performance Dividend Yield (as of June 30)
    DRDGOLD Ltd. (NYSE ADR: DRD) $3.19 -39.7% 10.24%
    Sibanye Gold Ltd. (NYSE ADR: SBGL) $4.70 -33.4% 5.98%
    Harmony Gold Mining Co. (NYSE ADR: HMY) $1.62 -26.7% 4.56%
    Gold Fields Limited (NYSE ADR: GFI) $3.41 +13.3% 2.73%
    Randgold Resources Ltd. (Nasdaq ADR: GOLD) $87.68 +14.9% 1.89%
    Franco Nevada Corp. (NYSE: FNV) $72.39 +21.1% 1.27%
    Royal Gold Inc. (Nasdaq: RGLD) $76.85 +21.3% 1.25%
    Eldorado Gold Corp. (NYSE: EGO) $2.58 -19.9% 1.16%
    Barrick Gold Corp. (NYSE: ABX) $15.90 -0.5% 0.75%
    Goldcorp Inc. (NYSE: GG) $13.02 -4.4% 0.62%

    Six of the 10 gold stocks listed above have posted negative returns so far in 2017. The main reason behind their losses has to do with gold price volatility.

Top 10 Medical Stocks To Invest In Right Now: Chesapeake Utilities Corporation(CPK)

Advisors’ Opinion:

  • [By Lisa Levin]

    On Tuesday, utilities shares slipped by just 0.5 percent. Meanwhile, top gainers in the sector included Pampa Energia S.A. (ADR) (NYSE: PAM), up 2 percent, and Chesapeake Utilities Corporation (NYSE: CPK) up 3 percent.

Top 10 Medical Stocks To Invest In Right Now: BanColombia S.A.(CIB)

Advisors’ Opinion:

  • [By Matt Smith]

    Bancolombia appears attractively priced
    Another Colombian company that appears under-valued is the Andean country’s largest commercial bank Bancolombia (NYSE: CIB  ) . For the year-to-date Bancolombia’s share price fell 17% because of a weak second quarter bottom-line. This decline was primarily caused by the bank’s net income plunging by 41% year-over-year because of mark-to-market losses caused by the value lost in the bank’s securities portfolio.

  • [By Javier Hasse]

    Analysts at Credit Suisse downgraded shares of Bancolombia SA (ADR) (NYSE: CIB) from Outperform to Neutral, while boosting their price target from $38 to $40.

  • [By Lisa Levin]

    Foreign Regional Banks: This industry declined 2 percent by 11:00 am with Bancolombia SA (ADR) (NYSE: CIB) moving down 3.7 percent. Bancolombia’s PEG ratio is 4.51.

Top 10 Medical Stocks To Invest In Right Now: Hudson Pacific Properties, Inc.(HPP)

Advisors’ Opinion:

  • [By Lisa Levin]

    Here is the list of stocks going ex-dividend on Friday.

    Douglas Dynamics Inc (NYSE: PLOW) – $0.2350 dividend, 2.9183 percent yield
    Tiffany & Co. (NYSE: TIF) – $0.4500 dividend, 2.6758 percent yield
    PulteGroup, Inc. (NYSE: PHM) – $0.0900 dividend, 1.7078 percent yield
    Leidos Holdings, Inc. (NYSE: LDOS) – $0.3200 dividend, 3.0851 percent yield
    Tupperware Brands Corporation (NYSE: TUP) – $0.6800 dividend, 4.1756 percent yield
    Hudson Pacific Properties Inc (NYSE: HPP) – $0.2000 dividend, 2.36

Top 5 Blue Chip Stocks To Watch Right Now

(Published Feb. 26 by Bob Ciura)

Finding stocks that have paid 100 years of dividends is no easy task. Couple this with a 3%-plus starting yield, and the task becomes that much harder.

CenterPoint Energy (NYSE:CNP) is one of a select few blue chip stocks that offers both. In fact, it goes even further – it has a 4% dividend yield.

It makes the list thanks to its steady business model. CenterPoint is an electric and gas utility, which is one of the most stable business models an investor can find.

CenterPoint recently increased its dividend by 4%, to $1.07 per share annualized. This was its 12th year in a row of consecutive dividend growth.

CenterPoint is a Dividend Achiever, a group of 272 stocks with 10-plus years of consecutive dividend increases.

You can see the full Dividend Achievers List here.

Business model

CenterPoint isn’t a run-of-the-mill utility. Most utility stocks are pure-play electric utilities.

Top 5 Blue Chip Stocks To Watch Right Now: Rockwell Collins, Inc.(COL)

Advisors’ Opinion:

  • [By Jayson Derrick]

    Honorable Mention: Rockwell Collins, Inc. (NYSE: COL) with a $122 price target.

    Technology, Media And Telecom

    Within the crowded technology, media and telecommunication group, Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL) is a top pick given its prospects for continued growth in mobile search and YouTube. Beyond these two segments, the analysts also see continued momentum in Alphabet’s core Google operations.

  • [By Lu Wang]

    Rockwell Collins (COL) sank 4.9 percent to $70.61. The maker of airplane cockpit instruments forecast revenue in fiscal 2014 will be no more than $4.60 billion. That missed the average analyst estimate of $4.93 billion in a Bloomberg survey.

  • [By Ben Levisohn]

    Rockwell Collins (COL) has fallen 2.6% to $68.21 after it was downgraded to Neutral from Outperform at Credit Suisse.

    General Electric (GE) has gained 1% to $24.25 after signing a bunch of deals and getting a positive mention from my colleague Jack Hough in this weekend’s Barron’s.

Top 5 Blue Chip Stocks To Watch Right Now: CYREN Ltd.(CYRN)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Cyren Ltd (NASDAQ: CYRN) got a boost, shooting up 41 percent to $2.33 after the company reported a strategic investment from Warburg Pincus Funds.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Tyson Foods, Inc. (NYSE: TSN) is expected to report quarterly earnings at $1.38 per share on revenue of $9.86 billion.
    Aecom (NYSE: ACM) is projected to report quarterly earnings at $0.71 per share on revenue of $4.67 billion.
    JD.Com Inc(ADR) (NASDAQ: JD) is estimated to report quarterly earnings at $0.11 per share on revenue of $12.60 billion.
    58.com Inc (ADR) (NYSE: WUBA) is projected to report quarterly earnings at $0.28 per share on revenue of $383.60 million.
    Kamada Ltd (NASDAQ: KMDA) is expected to report quarterly earnings at $0.02 per share on revenue of $25.00 million.
    Palatin Technologies, Inc. (NYSE: PTN) is projected to report quarterly earnings at $0.06 per share on revenue of $28.00 million.
    TheStreet, Inc. (NASDAQ: TST) is estimated to report a quarterly loss at $0.02 per share on revenue of $15.81 million.
    Atlantica Yield PLC (NASDAQ: ABY) is projected to report quarterly earnings at $0.45 per share on revenue of $290.80 million.
    Asure Software Inc (NASDAQ: ASUR) is estimated to report quarterly earnings at $0.15 per share on revenue of $15.26 million.
    Cyren Ltd (NASDAQ: CYRN) is expected to report quarterly loss at $0.06 per share on revenue of $7.90 million.
    Viewray Inc (NASDAQ: VRAY) is estimated to report quarterly loss at $0.12 per share on revenue of $18.58 million.

     

Top 5 Blue Chip Stocks To Watch Right Now: Hudson Pacific Properties, Inc.(HPP)

Advisors’ Opinion:

  • [By Lisa Levin]

    Here is the list of stocks going ex-dividend on Friday.

    Douglas Dynamics Inc (NYSE: PLOW) – $0.2350 dividend, 2.9183 percent yield
    Tiffany & Co. (NYSE: TIF) – $0.4500 dividend, 2.6758 percent yield
    PulteGroup, Inc. (NYSE: PHM) – $0.0900 dividend, 1.7078 percent yield
    Leidos Holdings, Inc. (NYSE: LDOS) – $0.3200 dividend, 3.0851 percent yield
    Tupperware Brands Corporation (NYSE: TUP) – $0.6800 dividend, 4.1756 percent yield
    Hudson Pacific Properties Inc (NYSE: HPP) – $0.2000 dividend, 2.36

Top 5 Blue Chip Stocks To Watch Right Now: CTI BioPharma Corp.(CTIC)

Advisors’ Opinion:

  • [By Ashley Moore]

    Here is a list of the top 10 best small-cap stocks based on price gains per share so far in 2017:

    Company (Ticker)Price per Share% Change AquaBounty Technologies Inc. (Nasdaq: AQB)$14.338,646.99%Rennova Health Inc. (Nasdaq: RNVA)$3.133,333.73%China Gengsheng Minerals Inc. (OTCMKTS: CHGS)$0.021,718.18%Sunshine Heart Inc. (Nasdaq: SSH)$3.851,071.43%CTI BioPharma Corp. (Nasdaq: CTIC)$4.30991.76%Catalyst Biosciences Inc. (Nasdaq: CBIO)$6.22853.85%TearLab Corp. (Nasdaq: TEAR)$4.20707.85%Pulmatrix Inc. (Nasdaq: PULM)$3.86566.10%Real Goods Solar Inc. (Nasdaq: RGSE)$1.43498.75%Calithera Biosciences Inc. (Nasdaq: CALA)$11.70281.54%

Top 5 Blue Chip Stocks To Watch Right Now: PetroChina Company Limited(PTR)

Advisors’ Opinion:

  • [By Money Morning News Team]

    PetroChina Co. Ltd. (NYSE ADR: PTR) is China’s largest oil company with a market cap of $216.52 billion. PTR is partially owned by the Chinese government.

Top 5 Heal Care Stocks To Watch For 2018

Uranium has been back in the news lately, not only due to its relationship with geopolitical maneuvering concerning nuclear weapons, but also as a necessary commodity in the global quest for clean, renewable energy.

The United States is the world’s largest producer of nuclear power, accounting for more than 30% of worldwide nuclear generation of electricity. While there has been little growth in new reactors being built in the last quarter century, the increasing demand for clean energy worldwide is sparking a demand for uranium to be enriched as nuclear fuel. Companies that mine and produce uranium, like Azincourt Uranium, Inc. (OTC: AZURF), are seeing the commodity investment market take a renewed interest in them, with uranium spot prices trending upward in the first quarter of 2017.

Top 5 Heal Care Stocks To Watch For 2018: Harmony Gold Mining Company Limited(HMY)

Advisors’ Opinion:

  • [By Lisa Levin]

    On Wednesday, basic materials shares surged by 0.6 percent. Top gainers in the sector included Harmony Gold Mining Co. (ADR) (NYSE: HMY) and Gold Fields Limited (ADR) (NYSE: GFI).

  • [By Javier Hasse]

    Harmony Gold Mining Co. (ADR) (NYSE: HMY) rose 2.2 percent on Friday, even though gold prices dropped. However, the stock lost 3.7 percent in after-hours trading, in what also seemed like a correction of the surge seen during the day.

  • [By Lisa Levin]

    In trading on Thursday, basic materials shares fell by 0.73 percent. Meanwhile, top losers in the sector included Silver Wheaton Corp. (USA) (NYSE: SLW), down 5 percent, and Harmony Gold Mining Co. (ADR) (NYSE: HMY), down 5 percent.

  • [By Lisa Levin] Gainers
    Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) shares rose 18.4 percent to $68.65 in pre-market trading as the company reported upbeat results for its first quarter.
    Jack in the Box Inc. (NASDAQ: JACK) shares rose 9.5 percent to $111.60 in the pre-market trading session after the company posted better-than-expected earnings for its second quarter. The company also disclosed that it has retained Morgan Stanley to evaluate potential alternatives for Qdoba.
    Coherus Biosciences Inc (NASDAQ: CHRS) rose 9.8 percent to $24.20 in pre-market trading. Coherus BioSciences disclosed that it prevailed in ‘135 IPR decision.
    Qiwi PLC (NASDAQ: QIWI) rose 8.1 percent to $21.49 in pre-market trading after reporting strong quarterly results.
    Korea Electric Power Corporation (ADR) (NYSE: KEP) shares rose 7.9 percent to $20.00 in pre-market trading after dropping 4.33 percent on Tuesday
    Target Corporation (NYSE: TGT) shares rose 7.5 percent to $58.60 in pre-market trading after the company reported stronger-than-expected results for its first quarter.
    AngloGold Ashanti Limited (ADR) (NYSE: AU) rose 4.3 percent to $11.71 in pre-market trading after falling 0.09 percent on Tuesday.
    Colgate-Palmolive Company (NYSE: CL) rose 4.1 percent to $74.53 in pre-market trading after the NY Post reported that the company might be up for sale for $100 per share.
    Harmony Gold Mining Co. (ADR) (NYSE: HMY) rose 4 percent to $2.35 in pre-market trading after declining 1.74 percent on Tuesday.
    Core Laboratories N.V. (NYSE: CLB) rose 3.6 percent to $109.00 in pre-market trading after gaining 0.39 percent on Tuesday.
    Clovis Oncology Inc (NASDAQ: CLVS) rose 3.2 percent to $51.15 in pre-market trading. JP Morgan upgraded Clovis Oncology from Neutral to Overweight.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Top 5 Heal Care Stocks To Watch For 2018: Cracker Barrel Old Country Store Inc.(CBRL)

Advisors’ Opinion:

  • [By Monica Gerson]

    Analysts are expecting Cracker Barrel Old Country Store, Inc. (NASDAQ: CBRL) to have earned $1.80 per share on revenue of $705.65 million in the latest quarter. Cracker Barrel shares gained 0.67 percent to $152.50 in after-hours trading.

  • [By Shauna O’Brien]

    Cracker Barrel Old Country Store, Inc. (CBRL) shares dropped over 4% on Wednesday morning after the company reported lower fourth quarter earnings and a weak outlook for its first quarter.

    The Lebanon, TN-based company reported fourth quarter earnings of $34.3 million, or $1.43 per share, down slightly from $34.7 million, or $1.47 per share, a year ago. On average, analysts expected to see earnings of $1.35 per share.

    Total revenue fell to $646.1 million from $700.01 million last year. Analysts expected to see revenue of $668.68 million.

    Cracker Barrel President and CEO Sandra Cochran commented: “The fourth quarter of fiscal 2013 represents the seventh consecutive quarter of year-over-year improvement in comparable store traffic, restaurant sales, and retail sales. The financial results of the fourth quarter and full year reflect the effective execution of our strategic plan. As we begin our 2014 fiscal year, we are poised to capitalize on the achievements of fiscal 2013.”

    For FY2013, CBRL’s earnings rose 14% to $117.27 million, while EPS rose to $4.90 per share. On an adjusted basis, earnings were $4.97 per share, up 15% from the year prior. Total revenue for the year was $2.64 billion, up 3% from a year ago.

    Looking forward, the company expects to see first quarter earnings between $1.05 and $1.15 per share. This estimate would fall significantly below the average analyst estimate of $1.32 per share.

    For FY2014, the company expects EPS in the range of $5.60 to $5.80 and revenue between $2.7 billion and $2.75 billion. Analysts expect to see earnings of $5.69 per share and $2.74 billion in revenue.

    Cracker Barrel shares were down $4.70, or 4.39%, during Wednesday morning trading. The stock is up 59% YTD.

  • [By Monica Gerson]

    Cracker Barrel Old Country Store, Inc. (NASDAQ: CBRL) is projected to report its quarterly earnings at $1.80 per share on revenue of $705.65 million.

  • [By Peter Graham]

    Mid capSouthern chicken restaurant stock Cracker Barrel Old Country Store, Inc (NASDAQ: CBRL) reported Q3 earnings before the market opened this morning.Total revenue was flat at $700.4 million as comparable store restaurant sales decreased 0.4% as a 2.1% decline in comparable store restaurant traffic was partially offset by a 1.7% increase in average check. The average menu price increase for the quarter was approximately 1.6% andcomparable store retail sales decreased 4.7% from the prior year quarter. Comparable store restaurant traffic, average check and comparable store restaurant sales and retail sales for the fiscal months of February, March, and April and the third quarter were as follows:

  • [By Jake L’Ecuyer]

    Cracker Barrel Old Country Store (NASDAQ: CBRL) shares tumbled 2.50 percent to $104.32 after the company reported a 1.1% drop in its fiscal fourth-quarter earnings and issued a downbeat Q1 forecast.

Top 5 Heal Care Stocks To Watch For 2018: NewJersey Resources Corporation(NJR)

Advisors’ Opinion:

  • [By Daniela Pylypczak]

    New Jersey Resources Corp.(NJR) announced on Tuesday that it will raise its quarterly dividend rate by 5%.

    The new quarterly dividend rate will be 42 cents per share, up 2 cents from the prior 40 cents per share rate. Annually, the dividend rate will now be $1.68 per share. The new rate will be effective with the dividend payable October 1, 2013 to shareholders of record on September 23, 2013.

    Commenting on the increase, Chairman and CEO Laurence M. Downes noted “Our shareowners look to us year after year for consistent financial performance and a competitive return on their investment.he action taken today by our board of directors allows us to increase our dividend for the 20th time in the last 18 years. This is an acknowledgement of our team’s unwavering focus to provide exceptional value for our customers and shareowners.”

    New Jersey Resources shares traded 0.06% lower during Tuesday’s session. Year-to-date, the stock is up 5.90%.

Top 5 Heal Care Stocks To Watch For 2018: Hudson Pacific Properties, Inc.(HPP)

Advisors’ Opinion:

  • [By Lisa Levin]

    Here is the list of stocks going ex-dividend on Friday.

    Douglas Dynamics Inc (NYSE: PLOW) – $0.2350 dividend, 2.9183 percent yield
    Tiffany & Co. (NYSE: TIF) – $0.4500 dividend, 2.6758 percent yield
    PulteGroup, Inc. (NYSE: PHM) – $0.0900 dividend, 1.7078 percent yield
    Leidos Holdings, Inc. (NYSE: LDOS) – $0.3200 dividend, 3.0851 percent yield
    Tupperware Brands Corporation (NYSE: TUP) – $0.6800 dividend, 4.1756 percent yield
    Hudson Pacific Properties Inc (NYSE: HPP) – $0.2000 dividend, 2.36

Top 5 Heal Care Stocks To Watch For 2018: Coherus BioSciences, Inc.(CHRS)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) shares rose 18.4 percent to $68.65 in pre-market trading as the company reported upbeat results for its first quarter.
    Jack in the Box Inc. (NASDAQ: JACK) shares rose 9.5 percent to $111.60 in the pre-market trading session after the company posted better-than-expected earnings for its second quarter. The company also disclosed that it has retained Morgan Stanley to evaluate potential alternatives for Qdoba.
    Coherus Biosciences Inc (NASDAQ: CHRS) rose 9.8 percent to $24.20 in pre-market trading. Coherus BioSciences disclosed that it prevailed in ‘135 IPR decision.
    Qiwi PLC (NASDAQ: QIWI) rose 8.1 percent to $21.49 in pre-market trading after reporting strong quarterly results.
    Korea Electric Power Corporation (ADR) (NYSE: KEP) shares rose 7.9 percent to $20.00 in pre-market trading after dropping 4.33 percent on Tuesday
    Target Corporation (NYSE: TGT) shares rose 7.5 percent to $58.60 in pre-market trading after the company reported stronger-than-expected results for its first quarter.
    AngloGold Ashanti Limited (ADR) (NYSE: AU) rose 4.3 percent to $11.71 in pre-market trading after falling 0.09 percent on Tuesday.
    Colgate-Palmolive Company (NYSE: CL) rose 4.1 percent to $74.53 in pre-market trading after the NY Post reported that the company might be up for sale for $100 per share.
    Harmony Gold Mining Co. (ADR) (NYSE: HMY) rose 4 percent to $2.35 in pre-market trading after declining 1.74 percent on Tuesday.
    Core Laboratories N.V. (NYSE: CLB) rose 3.6 percent to $109.00 in pre-market trading after gaining 0.39 percent on Tuesday.
    Clovis Oncology Inc (NASDAQ: CLVS) rose 3.2 percent to $51.15 in pre-market trading. JP Morgan upgraded Clovis Oncology from Neutral to Overweight.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Ben Levisohn]

    Today,Coherus BioSciences (CHRS) lost a patent case with AbbVie (ABBV) that would have allowed for a generic version of Humira. Citigroup’s Andrew Baum and Peter Verdult have the details:

    Agence France-Presse/Getty Images

    The Patent Trial and Appeal Boardjust announced that CHRSs IPR on the 166 Humira formulation patent was not instituted. We remind investors that Amgens IPR on the same 157 and 158 formulation patents were also not instituted. Any at risk launch on a formulation that potentially infringes 166, 157 or 158 would seem unlikely and carries a high risk thatAbbVie would attain a preliminary injunction. It is not clear whether either company could attempt launch with a formulation that does not infringe the patent estate. We note that Sandoz has uniquely not filed any IPR on any biosimilars. Sandoz has not announced the FDA has accepted their filing for their biosimilar adalimumab…We anticipate that the perceived historic relationship of the immunogenicity of Humira as it relates to dose stretching will form a key debate in the ongoing PTAB case…

    Following the decision of the PTAB not to institute CHRS IPR on the 166 Humira formulation patent, we continue to anticipate that first likely launch of biosimilar adalimumab (Humira) in the US will be delayed until 2020, in line with our published forecasts and biosimilar model. We anticipate the open IPR hearings for the 135 dosing patent on Humira (filed by Boehringer and Coherus) to begin in Feb 2017 with the ruling in May. We rateAbbVie a Buy. We continue to prefer BUY rated Bristol-Myers Squibb (BMY), Eli Lilly (LLY) among the US names.

    Shares of AbbVie have climbed 5.6% to $59.18 at 3:05 p.m. today, while Coherus BioSciences has tumbled 11% to $25.18,Bristol-Myers Squibb has gained 3% to $52.56, andEli Lilly has risen 1.7% to $73.70.

  • [By Lisa Levin]

    Coherus Biosciences Inc (NASDAQ: CHRS) shares shot up 23 percent to $13.70 after the company announced plans to raise up to $150 million in a private placement.